Manulife Financial Corp (MNQFF) stock analysis
Close on Oct 19, 2026Market cap $79.59BP/E 20.3Yield –
StockData Score
Prices as of Oct 30, 2026How the score works
Weak3 of 30 checks passed
Manulife Financial passes 3 of the 30 checks behind our score; 20 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 0/6
- Growth
- 1/6
- Past performance
- 2/6
- Financial health
- 0/6
- Dividend
- 0/6
What stands out
Earnings growth accelerating
Net income grew 3.5% over the last twelve months, against a 5-year average of -1.0% a year.
Net margin above its 5-year average
Net margin was 68.5% over the last twelve months, against a 5-year average of 39.1%.
Net margin above the industry
Manulife Financial's net margin of 68.5% is above the Life Insurance median of 6.5%.
What to watch
Return on equity under 15%
Return on equity was 11.0% over the last twelve months and averaged 8.6% over five years; we look for 15% on both.
Earnings shrank over 5 years
Net income shrank 1.0% a year on average over the last five fiscal years.
Revenue growing under 10% a year
Revenue grew 9.5% a year over the last three fiscal years, short of the 10% we look for.
Growing slower than the industry
Revenue grew 7.1% over the last twelve months; the Life Insurance median is 8.0%.
Valuation0/6
P/E against its history
Not enough price and earnings history to compare.
P/E against the industry
Needs positive earnings and enough profitable companies in the industry.
P/S against the industry
Not enough revenue data to compare.
P/B against the industry
Needs positive book value.
Price against fair value
We could not estimate a fair value: it needs at least two valuation methods with positive inputs.
Margin of safety
Depends on the fair value estimate.
Growth1/6
Revenue growing under 10% a year
Revenue grew 9.5% a year over the last three fiscal years, short of the 10% we look for.
EPS growth over 3 years
Needs positive EPS three years ago and today.
Earnings growth accelerating
Net income grew 3.5% over the last twelve months, against a 5-year average of -1.0% a year.
Growing slower than the industry
Revenue grew 7.1% over the last twelve months; the Life Insurance median is 8.0%.
Company guidance
No outlook found in earnings releases from the last twelve months.
Gross margin trend
Banks and insurers do not report gross profit.
Past performance2/6
Return on equity under 15%
Return on equity was 11.0% over the last twelve months and averaged 8.6% over five years; we look for 15% on both.
Return on assets under 1%
Return on assets was 0.6%; for a bank or insurer, 1% or more is considered good.
Return on equity below the industry
Manulife Financial's return on equity of 11.0% is below the Life Insurance median of 11.7%.
Earnings shrank over 5 years
Net income shrank 1.0% a year on average over the last five fiscal years.
Net margin above its 5-year average
Net margin was 68.5% over the last twelve months, against a 5-year average of 39.1%.
Net margin above the industry
Manulife Financial's net margin of 68.5% is above the Life Insurance median of 6.5%.
Financial health0/6
Debt level
Needs debt and equity figures.
Debt trend
Needs a balance sheet from five years ago with positive equity.
Debt coverage
Needs operating cash flow.
Interest coverage
Interest expense is not reported separately.
Short-term liquidity
Insurers do not split assets into current and non-current.
Bankruptcy risk (Altman Z)
The Altman model does not apply to insurers.
Dividend0/6
No dividend
Manulife Financial has not paid a dividend in the last twelve months.
Yield against Treasuries
No dividend.
Yield against the market
No dividend.
Dividend stability
No dividend.
Earnings cover
No dividend.
Cash-flow cover
No dividend.
Fair value
How we estimate itWe don't publish a fair value for Manulife Financial. It needs a US-dollar share price, at least two valuation methods with positive inputs (earnings, EBITDA, book value or sales) and, for companies with several share classes, classes that trade at the same price.
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $58.61M
- Value traded per 1% price move
- $75.03M
Downside
Low risk
- Typical loss in a bad month
- 9.8%
- Volatility (annualized)
- 20%
- Sharpe ratio, 1 year
- 1.63
- Beta to the S&P 500 (5Y)
- 0.86
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2015 to 2025
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +7.1% | +9.5% | -36.5% | – | |
| Net income | +3.5% | – | -1.0% | – | |
| EPS, diluted | +8.1% | – | +0.9% | – |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | – | 11.6% | 11.0% | |
| Return on assets | – | 0.7% | 0.6% | |
| Debt to equity | 0.14 | 0.12 | – | |
| Diluted shares | 1.98B | 1.94B | 1.71B |
Cash use needs five years of cash flow figures
Manulife Financial does not report operating cash flow and capital expenditure for each of the last five fiscal years.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 68.5% | 0.01× | 19.83× | 11.0% |
| FY2024 | 71.0% | 0.01× | 18.92× | 11.0% |
| FY2023 | 75.6% | 0.01× | 18.20× | 10.9% |
| FY2022 | -31.2% | 0.01× | 19.10× | -4.2% |
| FY2021 | 11.5% | 0.07× | 18.51× | 14.5% |
| FY2020 | 7.4% | 0.09× | 16.65× | 11.6% |
| FY2019 | 7.0% | 0.10× | 16.40× | 11.8% |
| FY2018 | 12.3% | 0.05× | 17.01× | 11.0% |
| FY2017 | 3.6% | 0.08× | 17.51× | 5.1% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zeroC$5.57B
- Cash generatingOperating cash flow above zeroC$32.11B
- Return on assets improvedROA up on the prior year0.6% → 0.6%
- Earnings backed by cashOperating cash flow above net incomeC$32.11B vs C$5.57B
- Less leverageLong-term debt to assets fell0.7% → –
- Better liquidityCurrent ratio rose– → –
- No dilutionShare count did not rise1.78B → 1.71B
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose0.01 → 0.01